Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: Pharmacodynamics in relation to disposition

Darrell R. Abernethy, Jolanta Gutkowska, Lisa M. Winterbottom

Research output: Contribution to journalArticle

Abstract

Pharmacodynamics and disposition of amlodipine, a dihydropyndme calcium antagonist, were compared between elderly and young patients with hypertension. Elderly (mean ± SD; age, 68 ± 3 years) and young (35 ± 5 years) patients received single intravenous amlodipine doses followed by oral administration once daily for a total of 12 weeks. After intravenous administration, elderly patients had prolonged elimination half-life values (58 ± 11 versus 42 ± 8 hours; p <0.01) caused by decreased clearance (19 ± 5 versus 25 ± 7 L/hr;p <0.01). After a 3-months oral treatment washout period, half-life tended to be prolonged in the elderly patients (69 ± 20 hours for the elderly patients versus 53 ± 14 hours for the young patients; difference not significant) and was not markedly different from the short-term intravenous measurement. Both systolic and diastolic blood pressure were significantly decreased from baseline throughout the treatment period, with greater decreases in elderly patients for both systolic anddiastolic pressure. When amlodipine plasma concentration was correlated to change in mean blood pressure after short-term intravenous doses, elderly patients had a greater decrease than young patients at a given drug concentration. However, after long-term oral administration, elderly and young patients had comparable decreases in mean blood pressure at a given drug concentration, and the increased antihypertensive effect in the elderly was associated with somewhat higher amlodipine plasma concentration. Amlodipine administered once daily is an effective antihypertensive agent in elderly patients and young patients with essential hypertension.

Original languageEnglish (US)
Pages (from-to)76-86
Number of pages11
JournalClinical Pharmacology and Therapeutics
Volume48
Issue number1
StatePublished - Jul 1990
Externally publishedYes

Fingerprint

Amlodipine
Hypertension
Calcium
Blood Pressure
Antihypertensive Agents
Oral Administration
Half-Life
1,4-dihydropyridine
Pharmaceutical Preparations
Intravenous Administration

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension : Pharmacodynamics in relation to disposition. / Abernethy, Darrell R.; Gutkowska, Jolanta; Winterbottom, Lisa M.

In: Clinical Pharmacology and Therapeutics, Vol. 48, No. 1, 07.1990, p. 76-86.

Research output: Contribution to journalArticle

@article{473257d30a674d79aa19b91f8ba48f05,
title = "Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: Pharmacodynamics in relation to disposition",
abstract = "Pharmacodynamics and disposition of amlodipine, a dihydropyndme calcium antagonist, were compared between elderly and young patients with hypertension. Elderly (mean ± SD; age, 68 ± 3 years) and young (35 ± 5 years) patients received single intravenous amlodipine doses followed by oral administration once daily for a total of 12 weeks. After intravenous administration, elderly patients had prolonged elimination half-life values (58 ± 11 versus 42 ± 8 hours; p <0.01) caused by decreased clearance (19 ± 5 versus 25 ± 7 L/hr;p <0.01). After a 3-months oral treatment washout period, half-life tended to be prolonged in the elderly patients (69 ± 20 hours for the elderly patients versus 53 ± 14 hours for the young patients; difference not significant) and was not markedly different from the short-term intravenous measurement. Both systolic and diastolic blood pressure were significantly decreased from baseline throughout the treatment period, with greater decreases in elderly patients for both systolic anddiastolic pressure. When amlodipine plasma concentration was correlated to change in mean blood pressure after short-term intravenous doses, elderly patients had a greater decrease than young patients at a given drug concentration. However, after long-term oral administration, elderly and young patients had comparable decreases in mean blood pressure at a given drug concentration, and the increased antihypertensive effect in the elderly was associated with somewhat higher amlodipine plasma concentration. Amlodipine administered once daily is an effective antihypertensive agent in elderly patients and young patients with essential hypertension.",
author = "Abernethy, {Darrell R.} and Jolanta Gutkowska and Winterbottom, {Lisa M.}",
year = "1990",
month = "7",
language = "English (US)",
volume = "48",
pages = "76--86",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension

T2 - Pharmacodynamics in relation to disposition

AU - Abernethy, Darrell R.

AU - Gutkowska, Jolanta

AU - Winterbottom, Lisa M.

PY - 1990/7

Y1 - 1990/7

N2 - Pharmacodynamics and disposition of amlodipine, a dihydropyndme calcium antagonist, were compared between elderly and young patients with hypertension. Elderly (mean ± SD; age, 68 ± 3 years) and young (35 ± 5 years) patients received single intravenous amlodipine doses followed by oral administration once daily for a total of 12 weeks. After intravenous administration, elderly patients had prolonged elimination half-life values (58 ± 11 versus 42 ± 8 hours; p <0.01) caused by decreased clearance (19 ± 5 versus 25 ± 7 L/hr;p <0.01). After a 3-months oral treatment washout period, half-life tended to be prolonged in the elderly patients (69 ± 20 hours for the elderly patients versus 53 ± 14 hours for the young patients; difference not significant) and was not markedly different from the short-term intravenous measurement. Both systolic and diastolic blood pressure were significantly decreased from baseline throughout the treatment period, with greater decreases in elderly patients for both systolic anddiastolic pressure. When amlodipine plasma concentration was correlated to change in mean blood pressure after short-term intravenous doses, elderly patients had a greater decrease than young patients at a given drug concentration. However, after long-term oral administration, elderly and young patients had comparable decreases in mean blood pressure at a given drug concentration, and the increased antihypertensive effect in the elderly was associated with somewhat higher amlodipine plasma concentration. Amlodipine administered once daily is an effective antihypertensive agent in elderly patients and young patients with essential hypertension.

AB - Pharmacodynamics and disposition of amlodipine, a dihydropyndme calcium antagonist, were compared between elderly and young patients with hypertension. Elderly (mean ± SD; age, 68 ± 3 years) and young (35 ± 5 years) patients received single intravenous amlodipine doses followed by oral administration once daily for a total of 12 weeks. After intravenous administration, elderly patients had prolonged elimination half-life values (58 ± 11 versus 42 ± 8 hours; p <0.01) caused by decreased clearance (19 ± 5 versus 25 ± 7 L/hr;p <0.01). After a 3-months oral treatment washout period, half-life tended to be prolonged in the elderly patients (69 ± 20 hours for the elderly patients versus 53 ± 14 hours for the young patients; difference not significant) and was not markedly different from the short-term intravenous measurement. Both systolic and diastolic blood pressure were significantly decreased from baseline throughout the treatment period, with greater decreases in elderly patients for both systolic anddiastolic pressure. When amlodipine plasma concentration was correlated to change in mean blood pressure after short-term intravenous doses, elderly patients had a greater decrease than young patients at a given drug concentration. However, after long-term oral administration, elderly and young patients had comparable decreases in mean blood pressure at a given drug concentration, and the increased antihypertensive effect in the elderly was associated with somewhat higher amlodipine plasma concentration. Amlodipine administered once daily is an effective antihypertensive agent in elderly patients and young patients with essential hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0025289269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025289269&partnerID=8YFLogxK

M3 - Article

C2 - 2142447

AN - SCOPUS:0025289269

VL - 48

SP - 76

EP - 86

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -